33673238|t|Antiinflammatory Medicinal Plants from the Ugandan Greater Mpigi Region Act as Potent Inhibitors in the COX-2/PGH2 Pathway.
33673238|a|Our study investigates 16 medicinal plants via assessment of inhibition of proinflammatory enzymes such as cyclooxygenases (COX). The plants are used by traditional healers in the Greater Mpigi region in Uganda to treat inflammation and related disorders. We present results of diverse in vitro experiments performed with 76 different plant extracts, namely, (1) selective COX-2 and COX-1 inhibitor screening; (2) 15-LOX inhibition screening; (3) antibacterial resazurin assay against multidrug-resistant Staphylococcus aureus, Listeria innocua, Listeria monocytogenes, and Escherichia coli K12; (4) DPPH assay for antioxidant activity; and (5) determination of the total phenolic content (TPC). Results showed a high correlation between traditional use and pharmacological activity, e.g., extracts of 15 out of the 16 plant species displayed significant selective COX-2 inhibition activity in the PGH2 pathway. The most active COX-2 inhibitors (IC50 < 20 microg/mL) were nine extracts from Leucas calostachys, Solanum aculeastrum, Sesamum calycinum subsp. angustifolium, Plectranthus hadiensis, Morella kandtiana, Zanthoxylum chalybeum, and Warburgia ugandensis. There was no counteractivity between COX-2 and 15-LOX inhibition in these nine extracts. The ethyl acetate extract of Leucas calostachys showed the lowest IC50 value with 0.66 microg/mL (COX-2), as well as the most promising selectivity ratio with 0.1 (COX-2/COX-1). The TPCs and the EC50 values for DPPH radical scavenging activity showed no correlation with COX-2 inhibitory activity. This led to the assumption that the mechanisms of action are most likely not based on scavenging of reactive oxygen species and antioxidant activities. The diethyl ether extract of Harungana madagascariensis stem bark displayed the highest growth inhibition activity against S. aureus (MIC value: 13 microg/mL), L. innocua (MIC value: 40 microg/mL), and L. monocytogenes (MIC value: 150 microg/mL). This study provides further evidence for the therapeutic use of the previously identified plants used medicinally in the Greater Mpigi region.
33673238	0	16	Antiinflammatory	Disease	
33673238	104	109	COX-2	Gene	
33673238	110	114	PGH2	Gene	
33673238	231	246	cyclooxygenases	Gene	
33673238	248	251	COX	Gene	
33673238	344	356	inflammation	Disease	MESH:D007249
33673238	497	502	COX-2	Gene	
33673238	507	512	COX-1	Gene	
33673238	538	544	15-LOX	Gene	
33673238	585	594	resazurin	Chemical	MESH:C005843
33673238	629	650	Staphylococcus aureus	Species	1280
33673238	652	668	Listeria innocua	Species	1642
33673238	670	692	Listeria monocytogenes	Species	1639
33673238	698	718	Escherichia coli K12	Species	83333
33673238	724	728	DPPH	Chemical	MESH:C004931
33673238	796	804	phenolic	Chemical	-
33673238	989	994	COX-2	Gene	
33673238	1022	1026	PGH2	Gene	
33673238	1052	1057	COX-2	Gene	
33673238	1115	1133	Leucas calostachys	Species	483814
33673238	1135	1154	Solanum aculeastrum	Species	329759
33673238	1156	1180	Sesamum calycinum subsp.	Species	
33673238	1181	1194	angustifolium	Species	
33673238	1196	1218	Plectranthus hadiensis	Species	1281416
33673238	1220	1237	Morella kandtiana	Species	
33673238	1239	1260	Zanthoxylum chalybeum	Species	1671342
33673238	1266	1286	Warburgia ugandensis	Species	549619
33673238	1325	1330	COX-2	Gene	
33673238	1335	1341	15-LOX	Gene	
33673238	1381	1394	ethyl acetate	Chemical	MESH:C007650
33673238	1406	1424	Leucas calostachys	Species	483814
33673238	1475	1480	COX-2	Gene	
33673238	1541	1546	COX-2	Gene	
33673238	1547	1552	COX-1	Gene	
33673238	1588	1600	DPPH radical	Chemical	-
33673238	1648	1653	COX-2	Gene	
33673238	1775	1798	reactive oxygen species	Chemical	MESH:D017382
33673238	1831	1855	diethyl ether extract of	Chemical	-
33673238	1856	1892	Harungana madagascariensis stem bark	Species	
33673238	1950	1959	S. aureus	Species	
33673238	1987	1997	L. innocua	Species	1642
33673238	2029	2045	L. monocytogenes	Species	1639

